Literature DB >> 10780949

Decreased cardiac output at the onset of diabetes: renal mechanisms and peripheral vasoconstriction.

M W Brands1, S M Fitzgerald, W H Hewitt, A E Hailman.   

Abstract

Recently we reported that hindquarter blood flow, measured 24 h/day, decreased progressively over the first 6 days of type 1 diabetes in rats. That response, coupled with the tendency of mean arterial pressure to increase, suggested a vasoconstrictor response. The purpose of this study was to measure the changes in cardiac output together with the renal hemodynamic and excretory responses to allow integrative determination of whether vasoconstriction likely accompanies the onset of type 1 diabetes. Rats were instrumented with a Transonic flow probe on the ascending aorta and with artery and vein catheters, and cardiac output and mean arterial pressure were measured continuously, 24 h/day, throughout the study. The induction of diabetes, by withdrawing intravenous insulin-replacement therapy in streptozotocin-treated rats, caused a progressive decrease in cardiac output that was 85 +/- 5% of control levels by day 7. This was associated with significant increases in glomerular filtration rate, renal blood flow, and microalbuminuria as well as urinary fluid and sodium losses, with a negative cumulative sodium balance averaging 15.7 +/- 1.6 meq by day 7. Restoring insulin-replacement therapy reversed the renal excretory responses but did not correct the negative sodium balance, yet cardiac output returned rapidly to control values. Increasing sodium intake during the diabetic and recovery periods also did not significantly affect the cardiac output response during any period. These results indicate that cardiac output decreases significantly at the onset of type 1 diabetes without glycemic control, and although volume loss may contribute to this response, there also is a component that is not volume or sodium dependent. We suggest this may be due to vasoconstriction, but to what extent local blood flow autoregulation or active vasoconstriction may have mediated that response is not known.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780949     DOI: 10.1152/ajpendo.2000.278.5.E917

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

1.  PKPD modelling of the interrelationship between mean arterial BP, cardiac output and total peripheral resistance in conscious rats.

Authors:  N Snelder; B A Ploeger; O Luttringer; D F Rigel; R L Webb; D Feldman; F Fu; M Beil; L Jin; D R Stanski; M Danhof
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

2.  Physiological hyperinsulinemia caused by acute hyperglycemia minimizes renal sodium loss by direct action on kidneys.

Authors:  Debra L Irsik; Michael W Brands
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-05-23       Impact factor: 3.619

3.  The normal increase in insulin after a meal may be required to prevent postprandial renal sodium and volume losses.

Authors:  Debra L Irsik; Bonnie L Blazer-Yost; Alexander Staruschenko; Michael W Brands
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-03-22       Impact factor: 3.619

4.  NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy.

Authors:  Kirsten Thomsen; Inger Rubin; Martin Lauritzen
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

Review 5.  Role of glomerular filtration rate in controlling blood pressure early in diabetes.

Authors:  Michael W Brands; Hicham Labazi
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

6.  Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.

Authors:  Tracy D Bell; Gerald F DiBona; Rachel Biemiller; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27

Review 7.  Anti-Diabesity Middle Eastern Medicinal Plants and Their Action Mechanisms.

Authors:  Bashar Saad; Abdalsalam Kmail; Sameena Z H Haq
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-18       Impact factor: 2.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.